BioCentury
ARTICLE | Product Development

Europe’s five-year plan to tackle COVID-19 and other coronavirus threats

IMI-backed CARE alliance launches to develop coronavirus therapies

August 22, 2020 12:54 AM UTC

The latest alliance formed in the wake of COVID-19, CARE, is looking beyond the pandemic to future coronavirus threats. Filling its ranks are companies representing every step of the drug discovery and development process.

CARE (Corona Accelerated R&D in Europe), supported by Europe’s Innovative Medicines Initiative (IMI), brings together 37 teams from academic and non-profit research institutions and pharmaceutical companies to accelerate coronavirus therapeutic development, including for COVID-19. ...